Log in
Enquire now
MPM Capital

MPM Capital

U.S-based venture capital firm funding companies in U.S., Europe, and India.

OverviewStructured DataIssuesContributors

Contents

mpmcapital.com
Is a
Investor
Investor
Venture capital firm
Venture capital firm
Company
Company
Organization
Organization

Company attributes

Industry
Biology
Biology
Investment
Investment
Biotechnology
Biotechnology
Technology
Technology
Location
Cambridge, Massachusetts
Cambridge, Massachusetts
Boston
Boston
Massachusetts
Massachusetts
California
California
Brisbane, California
Brisbane, California
B2X
B2B
B2B
AngelList URL
angel.co/mpm-capital
Number of Employees (Ranges)
11 – 500
Email Address
info@mpmcapital.com
Phone Number
+16505533300
Investors
Entrada Therapeutics
Entrada Therapeutics
Founded Date
2000
0
Glassdoor ID
11542
Wellfound ID
mpm-capital

Venture Capital Firm attributes

Invested in
TV2 Holding
TV2 Holding
Syndax Pharmaceuticals
Syndax Pharmaceuticals
Epizyme
Epizyme
NeuroTherapeutics Pharma
NeuroTherapeutics Pharma
Aryx Therapeutics
Aryx Therapeutics
EndoGastric Solutions
EndoGastric Solutions
Selexys Pharmaceuticals
Selexys Pharmaceuticals
Elixir Pharmaceuticals
Elixir Pharmaceuticals
...

Other attributes

Company Operating Status
Active

MPM Capital is a venture capital firm founded in 1996. The firm was founded by Luke Evnin and Ansbert Gadicke. It is primarily based in Cambridge, Massachusetts although it also has offices in Brisbane, California and Kansas City, Kansas. As of March 2019, the firm is managing 33 active companies in its portfolio and has sold off its ownership in 199 companies. Its most recent investment was in Harpoon Therapeutics on November 2018, a company developing clinical-stage immunotherapy .

Funding

MPM Capital specializes in funding life sciences and healthcare companies. It provides financing at various stages of development, from seed to buyout. The firm invests on companies worldwide, but it prioritizes funding companies that are based in the United States, Europe, and India. Since its establishment, the firm has managed to amass a total fund of $2.9 billion across ten funding series. Its most recent funding round was held in February 2019 which collected $400 million.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Associated Investment Funds

Accelerator Batches

Patents

Funding Rounds Participated In

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like MPM Capital

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.